Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Bull Exp Biol Med ; 176(3): 359-362, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38342810

ABSTRACT

Ion channels activity is regulated through soluble guanylate cyclase (sGC) and adenylate cyclase (AC) pathways, while phosphodiesterases (PDE) control the intracellular levels of cAMP and cGMP. Here we applied RNA transcriptome sequencing to study changes in the gene expression of the sGC, AC, and PDE isoforms in isolated rat ventricular cardiomyocytes under conditions of microgravity and hypergravity. Our results demonstrate that microgravity reduces the expression of sGC isoform genes, while hypergravity increases their expression. For a subset of AC isoforms, gene expression either increased or decreased under both microgravity and hypergravity conditions. The expression of genes encoding 10 PDE isoforms decreased under microgravity, but increased under hypergravity. However, under both microgravity and hypergravity, the gene expression increased for 7 PDE isoforms and decreased for 3 PDE isoforms. Overall, our findings indicate specific gravity-dependent changes in the expression of genes of isoforms associated with the studied enzymes.


Subject(s)
Hypergravity , Weightlessness , Rats , Animals , Phosphoric Diester Hydrolases/metabolism , Soluble Guanylyl Cyclase , Adenylyl Cyclases/genetics , Myocytes, Cardiac/metabolism , Protein Isoforms/genetics , Guanylate Cyclase/genetics , Guanylate Cyclase/metabolism , Cyclic GMP/metabolism
2.
Biomed Khim ; 69(6): 394-402, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38153054

ABSTRACT

Hyperglycemia is one of the main damaging factors of diabetes mellitus (DM). The severity of this disease is most clearly manifested under conditions of the inflammatory process. In this work, we have studied the activation features of rat peritoneal macrophages (MPs) under conditions of high glucose concentration in vitro. Comparison of the independent and combined effects of streptozotocin-induced DM and hyperglycemia on proliferation and accumulation of nitrites in the MPs culture medium revealed similarity of their effects. Elevated glucose levels and, to a lesser extent, DM decreased basal proliferation and NO production by MPs in vitro. The use of the protein kinase C (PKC) activator, phorbol ester (PMA), abolished the proinflammatory effect of thrombin on PMs. This suggests the involvement of PKC in the effects of the protease. At the same time, the effect of thrombin on the level of nitrites in the culture medium demonstrates a pronounced dose-dependence, which was not recognized during evaluation of proliferation. Proinflammatory activation of MPs is potentiated by hyperglycemia, one of the main pathological factors of diabetes. Despite the fact that high concentrations of glucose have a significant effect on proliferation and NO production, no statistically significant differences were found between the responses of MPs obtained from healthy animals and from animals with streptozotocin-induced DM. This ratio was observed for all parameters studied in the work, during analysis of cell proliferation and measurement of nitrites in the culture medium. Thus, the results obtained indicate the leading role of elevated glucose levels in the regulation of MPs activation, which is comparable to the effect of DM and even "masks" it.


Subject(s)
Diabetes Mellitus, Experimental , Hyperglycemia , Rats , Animals , Macrophages, Peritoneal/metabolism , Nitrites , Streptozocin/metabolism , Streptozocin/pharmacology , Thrombin/metabolism , Thrombin/pharmacology , Hyperglycemia/metabolism , Protein Kinase C/metabolism , Protein Kinase C/pharmacology , Glucose/metabolism
3.
Zh Nevrol Psikhiatr Im S S Korsakova ; 118(12. Vyp. 2): 38-45, 2018.
Article in Russian | MEDLINE | ID: mdl-30830115

ABSTRACT

This paper presents a literature review considering the role and mechanism of apoptosis in the pathogenesis of ischemic stroke (IS). The authors introduce a new concept: the functional request of the patient as a set of external (the nature and intensity of rehabilitation measures, characteristics of everyday life, diet, etc.) and internal (genetic factors, internal picture of the disease, availability of rental and other psychological facilities and etc.) attributes. This concept allows a new angle in understanding the pathogenesis of IS and creates fundamental and clinical potential for more successful approaches to therapy and rehabilitation after IS.


Subject(s)
Apoptosis , Brain Ischemia , Stroke Rehabilitation , Stroke , Humans , Stroke/physiopathology
4.
Bull Exp Biol Med ; 163(5): 583-585, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28948553

ABSTRACT

Discrete mechanical stretch of isolated spontaneously contracting cardiac myocytes was employed to examine the kinetics of NO production in these cells. NO oscillations were detected with fluorescent dye 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate. The mechanisms underlying stretch-induced changes in NO concentration remain unclear and further studies are needed to evaluate the role of NO oscillation in the regulation of cardiomyocyte function.


Subject(s)
Myocytes, Cardiac/metabolism , Nitric Oxide/metabolism , Animals , Cells, Cultured , Fluoresceins/pharmacology , Kinetics , Myocytes, Cardiac/drug effects , Rats , Stress, Mechanical
5.
Biochemistry (Mosc) ; 82(7): 778-790, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28918742

ABSTRACT

Key hemostatic serine proteases such as thrombin and activated protein C (APC) are signaling molecules controlling blood coagulation and inflammation, tissue regeneration, neurodegeneration, and some other processes. By interacting with protease-activated receptors (PARs), these enzymes cleave a receptor exodomain and liberate new amino acid sequence known as a tethered ligand, which then activates the initial receptor and induces multiple signaling pathways and cell responses. Among four PAR family members, APC and thrombin mainly act via PAR1, and they trigger divergent effects. APC is an anticoagulant with antiinflammatory and cytoprotective activity, whereas thrombin is a protease with procoagulant and proinflammatory effects. Hallmark features of APC-induced effects result from acting via different pathways: limited proteolysis of PAR1 localized in membrane caveolae with coreceptor (endothelial protein C receptor) as well as its targeted proteolytic action at a receptor exodomain site differing from the canonical thrombin cleavage site. Hence, a new noncanonical tethered PAR1 agonist peptide (PAR1-AP) is formed, whose effects are poorly investigated in inflammation, tissue regeneration, and neurotoxicity. In this review, a concept about a role of biased agonism in effects exerted by APC and PAR1-AP via PAR1 on cells involved in inflammation and related processes is developed. New evidence showing a role for a biased agonism in activating PAR1 both by APC and PAR1-AP as well as induction of antiinflammatory and cytoprotective cellular responses in experimental inflammation, wound healing, and excitotoxicity is presented. It seems that synthetic PAR1 peptide-agonists may compete with APC in controlling some inflammatory and neurodegenerative diseases.


Subject(s)
Inflammation , Protein C/metabolism , Regeneration/physiology , Thrombin/metabolism , Apoptosis/drug effects , Blood Coagulation Factors/agonists , Blood Coagulation Factors/metabolism , Glutamic Acid/toxicity , Humans , Mast Cells/cytology , Mast Cells/drug effects , Mast Cells/metabolism , Neuroprotective Agents/pharmacology , Receptor, PAR-1/agonists , Receptor, PAR-1/metabolism , Receptors, Cell Surface/agonists , Receptors, Cell Surface/metabolism
6.
Biochemistry (Mosc) ; 82(6): 737-749, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28601083

ABSTRACT

The MTT assay based on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium in the cell cytoplasm to a strongly light absorbing formazan is among the most commonly used methods for determination of cell viability and activity of NAD-dependent oxidoreductases. In the present study, the effects of MTT (0.1 mg/ml) on mitochondrial potential (ΔΨm), intracellular NADH, and respiration of cultured rat cerebellum neurons and isolated rat liver mitochondria were investigated. MTT caused rapid quenching of NADH autofluorescence, fluorescence of MitoTracker Green (MTG) and ΔΨm-sensitive probes Rh123 (rhodamine 123) and TMRM (tetramethylrhodamine methyl ester). The Rh123 signal, unlike that of NADH, MTG, and TMRM, increased in the nucleoplasm after 5-10 min, and this was accompanied by the formation of opaque aggregates of formazan in the cytoplasm and neurites. Increase in the Rh123 signal indicated diffusion of the probe from mitochondria to cytosol and nucleus due to ΔΨm decrease. Inhibition of complex I of the respiratory chain decreased the rate of formazan formation, while inhibition of complex IV increased it. Inhibition of complex III and ATP-synthase affected only insignificantly the rate of formazan formation. Inhibition of glycolysis by 2-deoxy-D-glucose blocked the MTT reduction, whereas pyruvate increased the rate of formazan formation in a concentration-dependent manner. MTT reduced the rate of oxygen consumption by cultured neurons to the value observed when respiratory chain complexes I and III were simultaneously blocked, and it suppressed respiration of isolated mitochondria if substrates oxidized by NAD-dependent dehydrogenases were used. These results demonstrate that formazan formation in cultured rat cerebellum neurons occurs primarily in mitochondria. The initial rate of formazan formation may serve as an indicator of complex I activity and pyruvate transport rate.


Subject(s)
Cerebellum/metabolism , Membrane Potential, Mitochondrial/drug effects , Mitochondria/metabolism , Neurites/metabolism , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Animals , Cell Survival/drug effects , Cells, Cultured , Cerebellum/cytology , Electron Transport Complex I/metabolism , Electron Transport Complex III/metabolism , Mitochondrial Proteins/metabolism , Rats , Rats, Wistar
7.
Bull Exp Biol Med ; 157(4): 530-4, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25110099

ABSTRACT

The effects of activated protein C (APC) on the quantitative parameters of neurons and neuroglia in the perifocal zone of infarction induced in the left hemispheric cortex were studied in two groups of rats. Group 1 animals served as control (control infarction). Group 2 rats were injected with APC (50 µg/kg) in the right lateral cerebral ventricle 3 h after infarction was induced, and after 72 h the infarction size was evaluated and the neurons and neuroglia in the perifocal zone were counted. APC reduced the infarction size 2.5 times in comparison with the control and reduced by 16% the neuronal death in the perifocal zone layer V, causing no appreciable changes in layer III, and did not change the size of neuronal bodies but increased (by 11%) the size of neuronal nuclei in layer III. The protein maintained the sharply increased count of gliocytes in the perifocal zone of infarction and promoted their growth. Hence, APC protected the neurons from death in the ischemic focus by increasing the gliocyte count and stimulating the compensatory reparative processes.


Subject(s)
Brain Ischemia/drug therapy , Neuroglia/drug effects , Neurons/drug effects , Neuroprotective Agents/pharmacology , Protein C/pharmacology , Stroke/drug therapy , Animals , Animals, Outbred Strains , Brain Ischemia/pathology , Cell Count , Cell Death/drug effects , Cerebral Ventricles/pathology , Coronary Occlusion/pathology , Injections, Intraventricular , Male , Middle Cerebral Artery/pathology , Neuroglia/pathology , Neurons/pathology , Protein C/agonists , Rats , Stroke/pathology
8.
Biochemistry (Mosc) ; 79(2): 146-57, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24794730

ABSTRACT

For the first time, simultaneous monitoring of changes in the concentration of cytosolic ATP ([ATP]c), pH (pHc), and intracellular free Ca2+ concentration ([Ca2+]i) of the individual neurons challenged with toxic glutamate (Glu) concentrations was performed. To this end, the ATP-sensor AT1.03, which binds to ATP and therefore enhances the efficiency of resonance energy transfer between blue fluorescent protein (energy donor) and yellow-green fluorescent protein (energy acceptor), was expressed in cultured hippocampal neurons isolated from 1-2-day-old rat pups. Excitation of fluorescence in the acceptor protein allowed monitoring changes in pHc. Cells were loaded with fluorescent low-affinity Ca2+ indicators Fura-FF or X-rhod-FF to register [Ca2+]i. It was shown that Glu (20 µM, glycine 10 µM, Mg2+-free) produced a rapid acidification of the cytosol and decrease in [ATP]c. An approximately linear relationship (r(2) = 0.56) between the rate of [ATP]c decline and latency of glutamate-induced delayed calcium deregulation (DCD) was observed: higher rate of [ATP]c decrease corresponded to shorter DCD latency period. DCD began with a decrease in [ATP]c of as much as 15.9%. In the phase of high [Ca2+]i, the plateau of [ATP]c dropped to 10.4% compared to [ATP]c in resting neurons (100%). In the presence of the Na+/K+-ATPase inhibitor ouabain (0.5 mM), glutamate-induced reduction in [ATP]c in the phase of the high [Ca2+]i plateau was only 36.6%. Changes in [ATP]c, [Ca2+]i, mitochondrial potential, and pHc in calcium-free or sodium-free buffers, as well as in the presence of the inhibitor of Na+/K+-ATPase ouabain (0.5 mM), led us to suggest that in addition to increase in proton conductivity and decline in [ATP]c, one of the triggering factors of DCD might be a reversion of the neuronal plasma membrane Na+/Ca2+ exchange.


Subject(s)
Adenosine Triphosphate/metabolism , Calcium/metabolism , Cytosol/drug effects , Cytosol/metabolism , Glutamic Acid/pharmacology , Homeostasis/drug effects , Neurons/cytology , Animals , Cells, Cultured , Cytosol/chemistry , Hydrogen-Ion Concentration , Membrane Potential, Mitochondrial/drug effects , Neurons/drug effects , Rats
9.
Biomed Khim ; 60(6): 702-6, 2014.
Article in Russian | MEDLINE | ID: mdl-25552512

ABSTRACT

Activated protein C (APC) is serine protease hemostasis, independent of its anticoagulant activity, exhibits anti-inflammatory and anti-apoptotic properties that determine the possibility of the protective effects of APC in different diseases, including sepsis and chronic wound healing. APC, binding of endothelial protein C receptor (EPCR) and specifically cleaving PAR1 receptor and releasing peptide agonist PAR1 stabilizes not only endothelial cells, but also many others, including epidermal keratinocytes of the skin. We develop the hypothesis that the cytoprotective effect of APC on the cells, involved in wound healing, seem to imitate peptide - analogous of PAR1 "tethered ligand" that activate PAR1. In our work, we synthesized a peptide (AP9) - analogue of PAR1 tethered ligand, released by APC, and firstly showed that peptide AP9 (0.1-10 мM), like to APC (0.01-100 nM), stimulates the proliferative activity of human primary keratinocytes. Using a model of the formation of epithelial wounds in vitro we found that peptide AP9, as well as protease APC, accelerates wound healing. Using specific antibodies to the receptor PAR1 and EPCR was studied the receptor mechanism of AP9 action in wound healing compared with the action of APС. The necessity of both receptors - PAR1 and EPСR, for proliferative activity of agonists was revealed. Identified in our work imitation by peptide AP9 - PAR1 ligand, APC acts on keratinocytes suggests the possibility of using a peptide AP9 to stimulate tissue repair.


Subject(s)
Antigens, CD/metabolism , Keratinocytes/drug effects , Peptides/pharmacology , Protein C/pharmacology , Receptor, PAR-1/metabolism , Receptors, Cell Surface/metabolism , Wound Healing/drug effects , Amino Acid Sequence , Antigens, CD/genetics , Cell Line , Cell Proliferation/drug effects , Cytoprotection , Endothelial Protein C Receptor , Gene Expression Regulation , Humans , Keratinocytes/cytology , Keratinocytes/metabolism , Ligands , Models, Biological , Molecular Mimicry , Molecular Sequence Data , Peptides/chemical synthesis , Peptides/metabolism , Primary Cell Culture , Protein C/chemistry , Protein C/metabolism , Receptor, PAR-1/agonists , Receptor, PAR-1/genetics , Receptors, Cell Surface/genetics , Signal Transduction
10.
Biochemistry (Mosc) ; 75(9): 1153-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21077835

ABSTRACT

The effects of full-size bovine enteropeptidase (BEK) and of human recombinant light chain enteropeptidase (L-HEP) on survival of cultured hippocampal neurons were studied under conditions of glutamate excitotoxicity. Low concentrations of L-HEP or BEK (0.1-1 and 0.1-0.5 nM, respectively) protected hippocampal neurons against the death caused by 100 µM glutamate. Using the PAR1 (proteinase-activated receptor) antagonist SCH 79797, we revealed a PAR1-dependent mechanism of neuroprotective action of low concentrations of enteropeptidase. The protective effect of full-size enteropeptidase was not observed at the concentrations of 1 and 10 nM; moreover, 10 nM of BEK caused death of 88.9% of the neurons, which significantly exceeded the cell death caused by glutamate (31.9%). Under conditions of glutamate cytotoxicity the survival of neurons was 26.8% higher even in the presence of 10 nM of L-HEP than in the presence of 10 nM BEK. Pretreatment of cells with 10 nM of either form of enteropeptidase abolished the protective effect of 10 nM thrombin under glutamate cytotoxicity. High concentrations of BEK and L-HEP caused the death of neurons mainly through necrosis.


Subject(s)
Enteropeptidase/metabolism , Glutamic Acid/toxicity , Hippocampus/cytology , Neurons/drug effects , Animals , Cattle , Cell Survival , Cells, Cultured , Enteropeptidase/genetics , Humans , Neurons/metabolism , Pyrroles/pharmacology , Quinazolines/pharmacology , Receptor, PAR-1/antagonists & inhibitors , Receptor, PAR-1/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Thrombin/pharmacology
11.
Biochemistry (Mosc) ; 73(6): 717-24, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18620539

ABSTRACT

The effect of an anticoagulant and cytoprotector blood serine proteinase--activated protein C (APC)--on survival of cultured hippocampal and cortical neurons under conditions of glutamate-induced excitotoxicity has been studied. Low concentrations of APC (0.01-10 nM) did not cause neuron death, but in the narrow range of low concentrations APC twofold and stronger decreased cell death caused by glutamate toxicity. High concentrations of APC (>50 nM) induced the death of hippocampal neurons similarly to the toxic action of glutamate. The neuroprotective effect of APC on the neurons was mediated by type 1 proteinase-activated receptor (PAR1), because the inactivation of the enzyme with phenylmethylsulfonyl fluoride or PAR1 blockade by a PAR1 peptide antagonist ((Tyr1)-TRAP-7) prevented the protective effect of APC. Moreover, APC inhibited the proapoptotic effect of 10 nM thrombin on the neurons. Geldanamycin, a specific inhibitor of heat shock protein Hsp90, completely abolished the antiapoptotic effect of 0.1 nM APC on glutamate-induced cytotoxicity in the hippocampal neurons. Thus, APC at low concentrations, activating PAR1, prevents the death of hippocampal and cortical neurons under conditions of glutamate excitotoxicity.


Subject(s)
Glutamic Acid/pharmacology , Neurons/drug effects , Protein C/metabolism , Protein C/pharmacology , Receptor, PAR-1/physiology , Animals , Animals, Newborn , Benzoquinones/pharmacology , Cell Survival/drug effects , Cells, Cultured , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/physiology , Cytoprotection/drug effects , Cytotoxins/metabolism , Cytotoxins/pharmacology , Enzyme Inhibitors/pharmacology , Glutamic Acid/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/physiology , Lactams, Macrocyclic/pharmacology , Neurons/physiology , Neuroprotective Agents/pharmacology , Peptide Fragments/pharmacology , Protein C/physiology , Rats , Rats, Wistar , Receptor, PAR-1/agonists , Receptor, PAR-1/antagonists & inhibitors , Thrombin/pharmacology
12.
Biomed Khim ; 54(6): 649-58, 2008.
Article in Russian | MEDLINE | ID: mdl-19205424

ABSTRACT

Some serine proteinases of haemostasis can regulate blood clotting and inflammation acting at proteinase-activated receptors (PARs). It is known that the anticoagulant proteinase, activated protein C (APC), exhibits anti-inflammatory effects on endothelial cells and macrophages and this involves endothelial protein C receptor--EPCR and proteinase-activated receptor--PAR1. We have studied the effect of wide range of APC concentrations on functional activity of rat peritoneal mast cells (PMC), which secrete the proinflammatory mediators, under normal conditions and during acute inflammation in rats. APC was able to reduce beta-hexosaminidase release from PMC. APC at very low concentrations (0.2-2 nM) modulated the mediator secretion from PMC under normal conditions and also during acute inflammation in rats. APC abolished the proinflammatory activity of duodenase (80 nM), the proteinase from gastrointestinal tract and mast cells. Mast cells pretreated with cathepsin G (PAR1 antagonist) or duodenase abolished protective antiinflammatory effect of low concentrations of APC on PMC degranulation. Our data indicated that blockade of the mast cells proinflammatory mediator secretion by APC involved PAR1 activation.


Subject(s)
Cathepsins/physiology , Mast Cells/metabolism , Protein C/physiology , Serine Endopeptidases/physiology , Acute Disease , Animals , Cathepsin G , Cell Degranulation , In Vitro Techniques , Male , Mast Cells/enzymology , Mast Cells/physiology , Peritoneal Cavity/pathology , Peritonitis/immunology , Peritonitis/pathology , Peritonitis/physiopathology , Rats , Rats, Wistar , Receptor, PAR-1/agonists , Receptor, PAR-1/antagonists & inhibitors , Thrombin/metabolism , beta-N-Acetylhexosaminidases/metabolism
13.
Biomed Khim ; 53(4): 412-26, 2007.
Article in Russian | MEDLINE | ID: mdl-18035722

ABSTRACT

Activated protein C (APC) regulates the functional activity of mast cells by reducing release of beta-hexosaminidase, the marker of mast cell degranulation. APC could modulate the cell secretion of both: the rest mast cells and the activated cells with degranulators, such as proteinase-activated receptor agonist peptide (PAR1-AP) and compound 48/80. PAR1 desensitization with thrombin abolishes the effect of low APC concentration (< or =1,5 nM) on beta-hexosaminidase release by mast cells. APC, inactivated with phenilmethylsulfonilftoride (PMSF), did non mimic the enzyme action on mast cells. The duodenal proteinase, duodenase, activates the peritoneal mast cell via PAR1. APC abolishes the proinflammatory action of duodenase and PAR1-AP by means of reducing release of mast cell mediators. Pretreatment of mast cell with L-NAME abolished these APC effects. Thus, APC-induced decrease of mediator release could be attributed to NO generation by mast cells. Our data indicate that PAR1 takes part in the mechanism of regulatory anti-inflammatory APC action.


Subject(s)
Cell Degranulation/physiology , Mast Cells/physiology , Protein C/physiology , Receptor, PAR-1/physiology , Animals , Cell Degranulation/drug effects , In Vitro Techniques , Male , Mast Cells/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/metabolism , Oligopeptides/pharmacology , Peritoneal Cavity/cytology , Protein C/pharmacology , Rats , Rats, Wistar , Receptor, PAR-1/agonists , Serine Endopeptidases/metabolism , Signal Transduction , p-Methoxy-N-methylphenethylamine/pharmacology
14.
Biochemistry (Mosc) ; 71(10): 1082-9, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17125455

ABSTRACT

Effects of thrombin, factor Xa (FXa), and protease-activated receptor 1 and 2 agonist peptides (PAR1-AP and PAR2-AP) on survival and intracellular Ca2+ homeostasis in hippocampal neuron cultures treated with cytotoxic doses of glutamate were investigated. It is shown that at low concentrations (

Subject(s)
Factor Xa/pharmacology , Neurons/drug effects , Thrombin/pharmacology , Animals , Calcium/metabolism , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Glutamates/toxicity , Hippocampus/cytology , Neurons/cytology , Neurons/metabolism , Rats , Rats, Wistar
15.
Biomed Khim ; 52(1): 83-94, 2006.
Article in Russian | MEDLINE | ID: mdl-16739924

ABSTRACT

Thrombin receptor agonist peptide (TRAP-6) may effectively replace thrombin for stimulation of damaged tissue regeneration. (Thrombin employment is limited by its high cost, instability and proinflammatory effect at high concentrations.) Immobilization of TRAP-6 into a poly(D,L)-lactide-co-glycolide (PLGA)-based matrix can protect peptides from a destruction by peptidases located in a wound area, and can also provide controlled release of the peptide. PLGA microparticles with immobilized peptide were produced by double emulsion/evaporation technique. An observation of microparticle morphology by scanning electron microscopy highlighted that peptide immobilization resulted in the increase of the microparticle porosity. TRAP-6 release kinetics was characterized by burst increase of TRAP-6 concentration in HEPES buffer solution (pH 7.5) for first 2 hours from the beginning of the experiment, and TRAP-6 complete release occurred for 20 hours. An investigation of TRAP-6 destruction by scanning electron microscopy revealed that the increase of microparticle size and surface porosity were observed already after 1 day of incubation in the buffer solution, and an aggregation of destructing microparticles was obvious by the 7th day of the incubation. Thus, peptide immobilization into PLGA microparticles can allow to develop a novel controlled release drug delivery system.


Subject(s)
Biocompatible Materials/chemistry , Lactic Acid/chemistry , Peptide Fragments/chemistry , Polyglycolic Acid/chemistry , Polymers/chemistry , Receptors, Thrombin/agonists , Wound Healing , Biodegradation, Environmental , Delayed-Action Preparations , Microscopy, Electron, Scanning , Microspheres , Polylactic Acid-Polyglycolic Acid Copolymer
16.
Bull Exp Biol Med ; 142(4): 403-5, 2006 Oct.
Article in English, Russian | MEDLINE | ID: mdl-17415421

ABSTRACT

Generation of thrombin and activated protein C in the inflammatory focus was demonstrated in rats with experimental acute peritonitis. The contents of thrombin and activated protein C peaked by the 30th and 120th minute of inflammation, respectively. In vitro study showed a decrease in spontaneous and compound 48/80-induced secretion of beta-hexosaminidase by peritoneal mast cells under the influence of activated protein C in low concentrations. The antiinflammatory effect of protein C in the focus of acute peritonitis is probably realized through NO release from peritoneal mast cells. This conclusion is derived from the data that L-NAME abolishes the protective effect of activated protein C.


Subject(s)
Mast Cells/metabolism , Protein C/pharmacology , Amidohydrolases/metabolism , Animals , Inflammation/physiopathology , Male , Mast Cells/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Peritoneal Cavity , Rats , Rats, Wistar , Thrombin/metabolism
17.
Bull Exp Biol Med ; 140(3): 285-8, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16307037

ABSTRACT

Survival of cultured rat hippocampal neurons was estimated 4, 24, and 48 h after 15-min exposure to the toxic effect of glutamate under conditions of pre- or coincubation with 10 nM thrombin. Thrombin inhibited glutamate-induced apoptosis in neurons 24 and 48 h after treatment, but had no effect on necrosis. Selective peptide agonist of proteinase-activated type 1 receptors simulated, but receptor antagonist suppressed the neuroprotective effect of thrombin. Our results suggest that peptide antagonist of type 1 receptors play a role in the mechanisms of neuronal protection from glutamate toxicity.


Subject(s)
Glutamic Acid/toxicity , Receptor, PAR-1/physiology , Thrombin/pharmacology , Animals , Apoptosis/drug effects , Hippocampus/cytology , Neurons/drug effects , Oligopeptides/pharmacology , Rats , Rats, Wistar , Receptor, PAR-1/agonists , Receptor, PAR-1/antagonists & inhibitors , Receptor, PAR-1/drug effects
19.
Biokhimiia ; 58(11): 1779-87, 1993 Nov.
Article in Russian | MEDLINE | ID: mdl-8268314

ABSTRACT

A method has been developed for measuring the rates of rotenone-sensitive oxidation of NADH and oligomycin-sensitive hydrolysis of ATP in rat skeletal muscle homogenates. The method is based on the use of alamethicin which increases the permeability of the inner mitochondrial membrane for NADH and ATP. It has been shown that prolonged cold adaptation of rats (4 weeks, 4 degrees) does not change the activity of rotenone-sensitive NADH-oxidase in rat skeletal muscle homogenates which is equal to 12.4 +/- 4.4 nmol NADH/min/mg protein, but increases threefold that of F0F1-ATPase--from 31.8 +/- 7.4 up to 93.1 +/- 14.3 nmol P(i)/min/mg protein. It is suggested that prolonged cold adaptation induces structural-and-functional changes in the H(+)-ATP-synthetase complex of skeletal muscle mitochondria.


Subject(s)
Adaptation, Physiological , Muscles/enzymology , NAD/metabolism , Proton-Translocating ATPases/metabolism , Rotenone/pharmacology , Adenosine Triphosphate/metabolism , Animals , Cold Temperature , Intracellular Membranes/enzymology , Intracellular Membranes/metabolism , Male , Mitochondria, Muscle/enzymology , Mitochondria, Muscle/metabolism , Multienzyme Complexes/metabolism , Muscles/drug effects , Muscles/physiology , NADH, NADPH Oxidoreductases/metabolism , Oligomycins/pharmacology , Oxidation-Reduction , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...